IL15 and acute myeloid leukemia: To further test the anti-AML activity of the IL-15-expressing CAR-NK-92 cells, a stable, transplantable AML-PDX model was generated by passaging and expanding CD123+ AML cells obtained from an AML patient during routine diagnostics at the time of diagnosis through NSGS mice.